The Discounted Cash Flow (DCF) valuation of Castle Biosciences Inc (CSTL) is (64.14) USD. With the latest stock price at 33.79 USD, the upside of Castle Biosciences Inc based on DCF is -289.8%.
Based on the latest price of 33.79 USD and our DCF valuation, Castle Biosciences Inc (CSTL) is a sell. selling CSTL stocks now will result in a potential gain of 289.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 9.0% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (220.43) - (37.90) | (64.14) |
| Upside | -752.4% - -212.2% | -289.8% |